Edwards Lifesciences EW
-
Edwards Lifesciences ([[EW]] +2.7%) news roundup: Company authorizes a new $750M buyback program and says it will complete the remainder ($140M) of its previously authorized repurchase program during ...
Edwards Lifesciences ( EW +2.7% ) news roundup: Company authorizes a new $750M buyback program and says it will complete the remainder ($140M …
-
Healthcare Is Hot, But These 5 Are Not
… yield. What ails these laggards? Let's look at each of them to evaluate the prospects for a speedy recovery. Edwards Lifesciences ( EW ) (click to enlarge) EW was hammered following Complete Story »
-
New Morningstar Analyst Report for Edwards Lifesciences
… Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of ..... spinning off from Baxter International in 2000, Edwards Lifesciences has maintained its dominance in tissue heart valves …
-
Edwards Lifesciences Management Discusses Q1 2013 Results - Earnings Call Transcript
Edwards Lifesciences ( EW ) Q1 2013 Earnings Call April 23, 2013 5:00 pm ET Executives ..... a href='http://seekingalpha.com/article/1364391- edwards - lifesciences -management-discusses-q1-2013-results-earnings-call-transcript …
-
Edwards lowers outlook as sales disappoint; shares dive
(Reuters) - Edwards Lifesciences Corp on Tuesday lowered its 2013 outlook due to sluggish sales at the start of the year for its less-invasive replacement heart valves, and its shares plunged 15...
-
BRIEF- Edwards Lifesciences drops 14.6 percent in extended trade
NEW YORK, April 23 (Reuters) - Edwards Lifesciences Corp : * Drops 14.6 percent to $70.75 in extended trade after Q1 results, outlook
-
Edwards profit up on special payment; lowers outlook
April 23 (Reuters) - Edwards Lifesciences Corp said on Tuesday first-quarter net earnings more than doubled, boosted by a large gain from patent litigation with Medtronic Inc , but the heart valve maker lowered its 2013 outlook due to sluggish sales at the start of the year.
-
Edwards Lifesciences EW Q1 2013 Earnings Call Transcript
Greetings and welcome to the Edwards Lifesciences Corporation First Quarter 2013 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief …
-
Edwards heart valve system as good as surgery after 3 years -trial
SAN FRANCISCO, March 11 (Reuters) - Patients who received the original version of Edwards Lifesciences Corp's non-invasive heart valve replacement system had a nearly identical death rate after three years as those who had open-heart …
-
BRIEF-Death rate for Edwards Lifesciences' device and surgery identical after three years-study
March 11 (Reuters) - Edwards Lifesciences Corp : * Death rate for Edwards lifesciences ' sapien heart valve system and